ETHE1 and neoplasm: Additionally, mice injected (via lateral tail vein) with constitutively expressing ETHE1 HCT116 (1x106) or HT29 (1x106) cells show reduced median survival time, increased tumor incidence, tumor burden, multiplicity and metastasis in vivo.